| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |